Presseportal.de - Abbott Laboratories http://www.presseportal.de/pm/21683/abbott_laboratories/ Presseportal.de: Abbott Laboratories (Digitale Pressemappe) de-de news aktuell GmbH redaktion@presseportal.de Fri, 19 Mar 2010 00:00:01 +0100 Tue, 09 Mar 2010 22:55:00 +0200 6 http://www.presseportal.de/images/logo_napresseportal.gif Presseportal.de http://www.presseportal.de/pm/21683/abbott_laboratories/ Abbott Enhances Pharmaceutical Pipeline with Acquisition of Facet Biotech http://www.presseportal.de/pm/21683/1575044/abbott_laboratories/rss Abbott Laboratories: ABBOTT PARK, Illinois and REDWOOD CITY, California, March 9, 2010 (ots/PRNewswire) -- Abbott and Facet Biotech Corporation announced today a definitive agreement for Abbott to acquire Facet, enhancing Abbott's early- and mid-stage ... Abbott Laboratories [Pressemappe]
ABBOTT PARK, Illinois and REDWOOD CITY, California, March 9, 2010 (ots/PRNewswire) -- Abbott and Facet Biotech Corporation announced today a definitive agreement for Abbott to acquire Facet, enhancing Abbott's early- and mid-stage ... Lesen Sie hier weiter...
]]> http://www.presseportal.de/pm/21683/1575044/abbott_laboratories/rss Wirtschaft Tue, 09 Mar 2010 22:55:00 +0200 redaktion@presseportal.de Abbott Laboratories Twenty-Five Years of HIV Blood Testing Helped to Positively Transform Global Health Crisis http://www.presseportal.de/pm/21683/1570525/abbott_laboratories/rss Abbott Laboratories: Abbott Park, Illinois, March 2, 2010 (ots/PRNewswire) - Imagine delaying a life-saving surgery or being afraid to receive or donate blood for fear of contracting HIV (http://www.who.int/hiv/en/). It seems unbelievable today, but ... Abbott Laboratories [Pressemappe]
Abbott Park, Illinois, March 2, 2010 (ots/PRNewswire) - Imagine delaying a life-saving surgery or being afraid to receive or donate blood for fear of contracting HIV (http://www.who.int/hiv/en/). It seems unbelievable today, but ... Lesen Sie hier weiter...
]]> http://www.presseportal.de/pm/21683/1570525/abbott_laboratories/rss Wirtschaft Tue, 02 Mar 2010 13:32:00 +0200 redaktion@presseportal.de Abbott Laboratories Abbott Completes Acquisition of Solvay Pharmaceuticals http://www.presseportal.de/pm/21683/1562146/abbott_laboratories/rss Abbott Laboratories: Abbott Park, Illinois, February 16, 2010 (ots/PRNewswire) - Abbott today announced that it has completed its EUR 4.5 billion (US$6.2 billion) acquisition of Belgium-based Solvay Pharmaceuticals, providing Abbott with a large and ... Abbott Laboratories [Pressemappe]
Abbott Park, Illinois, February 16, 2010 (ots/PRNewswire) - Abbott today announced that it has completed its EUR 4.5 billion (US$6.2 billion) acquisition of Belgium-based Solvay Pharmaceuticals, providing Abbott with a large and ... Lesen Sie hier weiter...
]]> http://www.presseportal.de/pm/21683/1562146/abbott_laboratories/rss Wirtschaft Tue, 16 Feb 2010 07:31:00 +0200 redaktion@presseportal.de Abbott Laboratories Abbott to Suspend Marketing of Obesity Medicine Sibutramine in European Union Countries http://www.presseportal.de/pm/21683/1548548/abbott_laboratories/rss Abbott Laboratories: Abbott Park, Illinois (ots/PRNewswire) - Today the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) voted to recommend the suspension of marketing authorizations for all anti-obesity ... Abbott Laboratories [Pressemappe]
Abbott Park, Illinois (ots/PRNewswire) - Today the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) voted to recommend the suspension of marketing authorizations for all anti-obesity ... Lesen Sie hier weiter...
]]> http://www.presseportal.de/pm/21683/1548548/abbott_laboratories/rss Wirtschaft Thu, 21 Jan 2010 21:55:00 +0200 redaktion@presseportal.de Abbott Laboratories Abbott Receives European Regulatory Approval for New Ovarian Cancer Diagnostic Test http://www.presseportal.de/pm/21683/1544531/abbott_laboratories/rss Abbott Laboratories: Abbott Park, Illinois (ots/PRNewswire) - A new diagnostic tool, which studies show can aid in determining the risk of whether a pelvic mass is benign or malignant, is now available in Europe. This simple blood test is expected to help ... Abbott Laboratories [Pressemappe]
Abbott Park, Illinois (ots/PRNewswire) - A new diagnostic tool, which studies show can aid in determining the risk of whether a pelvic mass is benign or malignant, is now available in Europe. This simple blood test is expected to help ... Lesen Sie hier weiter...
]]> http://www.presseportal.de/pm/21683/1544531/abbott_laboratories/rss Wirtschaft Thu, 14 Jan 2010 15:31:00 +0200 redaktion@presseportal.de Abbott Laboratories New Abbott Gene-Based Test for Colorectal Cancer Receives CE Mark http://www.presseportal.de/pm/21683/1540418/abbott_laboratories/rss Abbott Laboratories: Des Plaines, Illinois (ots/PRNewswire) - Abbott announced today it has received CE Marking (Conformite Europeene) in the European Union for a new molecular diagnostic test, Abbott RealTime mS9 Colorectal Cancer, a non-invasive DNA ... Abbott Laboratories [Pressemappe]
Des Plaines, Illinois (ots/PRNewswire) - Abbott announced today it has received CE Marking (Conformite Europeene) in the European Union for a new molecular diagnostic test, Abbott RealTime mS9 Colorectal Cancer, a non-invasive DNA ... Lesen Sie hier weiter...
]]> http://www.presseportal.de/pm/21683/1540418/abbott_laboratories/rss Wirtschaft Wed, 06 Jan 2010 20:27:00 +0200 redaktion@presseportal.de Abbott Laboratories Abbott Announces Positive Three-Year Data on Its Fully Bioabsorbable Stent Technology, Initiates Large-Scale International Trial http://www.presseportal.de/pm/21683/1513240/abbott_laboratories/rss Abbott Laboratories: Orlando, Florida, November 16 (ots/PRNewswire) - - New ABSORB EXTEND Trial to Study Performance of Revolutionary Bioabsorbable Device in Approximately 1,000 Patients Abbott (NYSE: ABT) today announced three-year data from the ... Abbott Laboratories [Pressemappe]
Orlando, Florida, November 16 (ots/PRNewswire) - - New ABSORB EXTEND Trial to Study Performance of Revolutionary Bioabsorbable Device in Approximately 1,000 Patients Abbott (NYSE: ABT) today announced three-year data from the ... Lesen Sie hier weiter...
]]> http://www.presseportal.de/pm/21683/1513240/abbott_laboratories/rss Wirtschaft Mon, 16 Nov 2009 21:06:00 +0200 redaktion@presseportal.de Abbott Laboratories Abbott to Acquire Solvay Pharmaceuticals Business http://www.presseportal.de/pm/21683/1483062/abbott_laboratories/rss Abbott Laboratories: Abbott Park, Illinois (ots/PRNewswire) - - Diversifies Abbott's pharmaceutical products, expanding international growth platform - Supports long-term strategy to bolster presence in key global emerging markets - Adds ... Abbott Laboratories [Pressemappe]
Abbott Park, Illinois (ots/PRNewswire) - - Diversifies Abbott's pharmaceutical products, expanding international growth platform - Supports long-term strategy to bolster presence in key global emerging markets - Adds ... Lesen Sie hier weiter...
]]> http://www.presseportal.de/pm/21683/1483062/abbott_laboratories/rss Wirtschaft Mon, 28 Sep 2009 07:50:00 +0200 redaktion@presseportal.de Abbott Laboratories Results from Abbott's PROSPECT Study Provide New Insight into Role of Vulnerable Plaque in Coronary Artery Disease http://www.presseportal.de/pm/21683/1481846/abbott_laboratories/rss Abbott Laboratories: San Francisco (ots/PRNewswire) - Abbott (NYSE: ABT) today announced primary results from its groundbreaking PROSPECT (Providing Regional Observations to Study Predictors of Events in the Coronary Tree) clinical trial. PROSPECT is the ... Abbott Laboratories [Pressemappe]
San Francisco (ots/PRNewswire) - Abbott (NYSE: ABT) today announced primary results from its groundbreaking PROSPECT (Providing Regional Observations to Study Predictors of Events in the Coronary Tree) clinical trial. PROSPECT is the ... Lesen Sie hier weiter...
]]> http://www.presseportal.de/pm/21683/1481846/abbott_laboratories/rss Wirtschaft Thu, 24 Sep 2009 21:30:00 +0200 redaktion@presseportal.de Abbott Laboratories Abbott's XIENCE V(R) Demonstrates Significantly Lower Rates of MACE and Stent Thrombosis Compared to TAXUS(R) Liberte in Investigator-Initiated COMPARE Trial http://www.presseportal.de/pm/21683/1481085/abbott_laboratories/rss Abbott Laboratories: San Francisco (ots/PRNewswire) - - Independent Study of 1,800 Patients Affirms Outstanding Performance of XIENCE V vs. TAXUS Liberte Late-breaking data presented today from the COMPARE trial demonstrated that Abbott's (NYSE: ... Abbott Laboratories [Pressemappe]
San Francisco (ots/PRNewswire) - - Independent Study of 1,800 Patients Affirms Outstanding Performance of XIENCE V vs. TAXUS Liberte Late-breaking data presented today from the COMPARE trial demonstrated that Abbott's (NYSE: ... Lesen Sie hier weiter...
]]> http://www.presseportal.de/pm/21683/1481085/abbott_laboratories/rss Finanzen Wed, 23 Sep 2009 23:16:00 +0200 redaktion@presseportal.de Abbott Laboratories Abbott's XIENCE V(R) Superior to TAXUS(R) in Key Safety and Efficacy Measures in SPIRIT IV Trial http://www.presseportal.de/pm/21683/1481063/abbott_laboratories/rss Abbott Laboratories: San Francisco (ots/PRNewswire) - At One Year, XIENCE V Demonstrates: - Statistical Superiority on Primary Endpoint of Target Lesion Failure, with a 38 Percent Reduction Compared to TAXUS - 74 Percent Reduction in Stent ... Abbott Laboratories [Pressemappe]
San Francisco (ots/PRNewswire) - At One Year, XIENCE V Demonstrates: - Statistical Superiority on Primary Endpoint of Target Lesion Failure, with a 38 Percent Reduction Compared to TAXUS - 74 Percent Reduction in Stent ... Lesen Sie hier weiter...
]]> http://www.presseportal.de/pm/21683/1481063/abbott_laboratories/rss Wirtschaft Wed, 23 Sep 2009 20:15:00 +0200 redaktion@presseportal.de Abbott Laboratories Abbott's XIENCE V(R) Continues to Outperform TAXUS With Sustained Clinical Advantages and Impressive Long-Term Safety Results in SPIRIT III Trial http://www.presseportal.de/pm/21683/1479471/abbott_laboratories/rss Abbott Laboratories: San Francisco (ots/PRNewswire) - - Market-Leading XIENCE V Demonstrates Single-Digit Rate of Major Adverse Cardiac Events (MACE) at Three Years and a 43 Percent Reduction vs. TAXUS - No Additional Stent Thrombosis between Two ... Abbott Laboratories [Pressemappe]
San Francisco (ots/PRNewswire) - - Market-Leading XIENCE V Demonstrates Single-Digit Rate of Major Adverse Cardiac Events (MACE) at Three Years and a 43 Percent Reduction vs. TAXUS - No Additional Stent Thrombosis between Two ... Lesen Sie hier weiter...
]]> http://www.presseportal.de/pm/21683/1479471/abbott_laboratories/rss Wirtschaft Mon, 21 Sep 2009 17:07:00 +0200 redaktion@presseportal.de Abbott Laboratories Abbott Launches Next-Generation XIENCE PRIME(TM) Drug Eluting Stent in International Markets http://www.presseportal.de/pm/21683/1466377/abbott_laboratories/rss Abbott Laboratories: Barcelona, Spain (ots/PRNewswire) - - New Cobalt Chromium Stent Offers Enhanced Deliverability with a Broad Matrix of Sizes - Built Upon the Proven Track Record of Superior Clinical Outcomes of Abbott's Market-Leading XIENCE ... Abbott Laboratories [Pressemappe]
Barcelona, Spain (ots/PRNewswire) - - New Cobalt Chromium Stent Offers Enhanced Deliverability with a Broad Matrix of Sizes - Built Upon the Proven Track Record of Superior Clinical Outcomes of Abbott's Market-Leading XIENCE ... Lesen Sie hier weiter...
]]> http://www.presseportal.de/pm/21683/1466377/abbott_laboratories/rss Wirtschaft Mon, 31 Aug 2009 09:07:00 +0200 redaktion@presseportal.de Abbott Laboratories Abbott Receives CE Mark for Company's Next-Generation XIENCE PRIME(TM) Drug Eluting Stent, Advancing Leadership Position http://www.presseportal.de/pm/21683/1427851/abbott_laboratories/rss Abbott Laboratories: Abbott Park, Illinois (ots/PRNewswire) - - Broad Size Matrix of XIENCE PRIME to be Launched in Europe in the Third Quarter Abbott announced today that it has received CE Mark (Conformite Europeenne) for its next-generation ... Abbott Laboratories [Pressemappe]
Abbott Park, Illinois (ots/PRNewswire) - - Broad Size Matrix of XIENCE PRIME to be Launched in Europe in the Third Quarter Abbott announced today that it has received CE Mark (Conformite Europeenne) for its next-generation ... Lesen Sie hier weiter...
]]> http://www.presseportal.de/pm/21683/1427851/abbott_laboratories/rss Wirtschaft Tue, 23 Jun 2009 14:18:00 +0200 redaktion@presseportal.de Abbott Laboratories Abbott eröffnet in Singapur neue Herstellungseinrichtung für pädiatrische Nahrungsmittel http://www.presseportal.de/pm/21683/1360258/abbott_laboratories/rss Abbott Laboratories: Singapur (ots/PRNewswire) - - Mit Foto - Grösste Herstellungseinrichtung des Unternehmens für Nahrungsprodukte wird in Asien jährlich bis zu eine Million Säuglinge und Kinder bedienen - Bekanntgabe einer Vereinbarung ... Abbott Laboratories [Pressemappe]
Singapur (ots/PRNewswire) - - Mit Foto - Grösste Herstellungseinrichtung des Unternehmens für Nahrungsprodukte wird in Asien jährlich bis zu eine Million Säuglinge und Kinder bedienen - Bekanntgabe einer Vereinbarung ... Lesen Sie hier weiter...
]]> http://www.presseportal.de/pm/21683/1360258/abbott_laboratories/rss Vermischtes Fri, 27 Feb 2009 03:24:00 +0200 redaktion@presseportal.de Abbott Laboratories